Third-line Life-prolonging Drug Treatment in a Real-world Metastatic Castration-resistant Prostate Cancer Population:Results from the Dutch Castration-resistant Prostate Cancer Registry

Background: Evidence concerning third-line life-prolonging drugs (LPDs) in the treatment of metastatic castration-resistant prostate cancer (mCRPC) patients is incomplete. Objective: To evaluate third-line LPD outcomes in a real-world cohort of mCRPC patients, identify variables associated with overall survival (OS), and establish a prognostic model. Design, setting, and participants: Patients with mCRPC who were progressive on second-line LPD before July 1, 2017 were retrospectively identified from the Dutch Castration-resistant Prostate Cancer Registry (CAPRI) and followed until December 31,... Mehr ...

Volltext
Verfasser: Notohardjo, Jessica C.L.
Kuppen, Malou C.P.
Westgeest, Hans M.
van Moorselaar, Reindert J.A.
Mehra, Niven
Coenen, Jules L.L.M.
van Oort, Inge M.
de Vos, Aad I.
Vervenne, Walter L.
van den Bergh, Alphons C.M.
Aben, Katja K.H.
Somford, Diederik M.
Bergman, Andries M.
Uyl-de Groot, Carin A.
Gerritsen, Winald R.
van den Eertwegh, Alfons J.M.
Dokumenttyp: Artikel
Erscheinungsdatum: 2021
Reihe/Periodikum: Notohardjo , J C L , Kuppen , M C P , Westgeest , H M , van Moorselaar , R J A , Mehra , N , Coenen , J L L M , van Oort , I M , de Vos , A I , Vervenne , W L , van den Bergh , A C M , Aben , K K H , Somford , D M , Bergman , A M , Uyl-de Groot , C A , Gerritsen , W R & van den Eertwegh , A J M 2021 , ' Third-line Life-prolonging Drug Treatment in a Real-world Metastatic Castration-resistant Prostate Cancer Population : Results from the Dutch Castration-resistant Prostate Cancer Registry ' , European Urology Focus , vol. 7 , no. 4 , pp. 788-796 . https://doi.org/10.1016/j.euf.2020.03.009
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-28638012
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://research.vumc.nl/en/publications/53f15ea1-5a4f-49d5-b3d3-86f9c7e17ac8